Alex Thompson
Stock Analyst at Stifel
(1.72)
# 3,109
Out of 4,853 analysts
35
Total ratings
48.15%
Success rate
-8.73%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alex Thompson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics | Reinstates: Buy | $55 | $46.55 | +18.15% | 1 | May 20, 2025 | |
| TVTX Travere Therapeutics | Maintains: Hold | $22 → $23 | $14.94 | +53.95% | 3 | May 2, 2025 | |
| THRD Third Harmonic Bio | Downgrades: Hold | $23 → $5 | $5.29 | -5.39% | 2 | Mar 28, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $36 | $4.32 | +733.33% | 1 | Mar 25, 2025 | |
| CRNX Crinetics Pharmaceuticals | Initiates: Buy | $60 | $32.45 | +84.90% | 1 | Mar 25, 2025 | |
| ASND Ascendis Pharma | Maintains: Buy | $200 → $207 | $175.59 | +17.89% | 2 | Nov 15, 2024 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $49 | $12.05 | +306.64% | 1 | Oct 11, 2024 | |
| ARGX argenx SE | Maintains: Buy | $485 → $500 | $576.93 | -13.33% | 4 | Jun 24, 2024 | |
| SYRE Spyre Therapeutics | Reiterates: Buy | $36 → $54 | $16.58 | +225.69% | 2 | Mar 26, 2024 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $44 | $18.28 | +140.70% | 1 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $2 | $2.27 | -11.89% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $49.74 | +38.72% | 2 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $2 → $1 | $1.56 | -35.69% | 4 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $14.17 | +182.39% | 2 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $1.00 | +3,900.00% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $34 | $15.78 | +115.46% | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.63 | +1,930.77% | 1 | Dec 14, 2022 |
Kymera Therapeutics
May 20, 2025
Reinstates: Buy
Price Target: $55
Current: $46.55
Upside: +18.15%
Travere Therapeutics
May 2, 2025
Maintains: Hold
Price Target: $22 → $23
Current: $14.94
Upside: +53.95%
Third Harmonic Bio
Mar 28, 2025
Downgrades: Hold
Price Target: $23 → $5
Current: $5.29
Upside: -5.39%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $36
Current: $4.32
Upside: +733.33%
Crinetics Pharmaceuticals
Mar 25, 2025
Initiates: Buy
Price Target: $60
Current: $32.45
Upside: +84.90%
Ascendis Pharma
Nov 15, 2024
Maintains: Buy
Price Target: $200 → $207
Current: $175.59
Upside: +17.89%
Oruka Therapeutics
Oct 11, 2024
Initiates: Buy
Price Target: $49
Current: $12.05
Upside: +306.64%
argenx SE
Jun 24, 2024
Maintains: Buy
Price Target: $485 → $500
Current: $576.93
Upside: -13.33%
Spyre Therapeutics
Mar 26, 2024
Reiterates: Buy
Price Target: $36 → $54
Current: $16.58
Upside: +225.69%
Dianthus Therapeutics
Feb 15, 2024
Initiates: Buy
Price Target: $44
Current: $18.28
Upside: +140.70%
Dec 18, 2023
Maintains: Hold
Price Target: $6 → $2
Current: $2.27
Upside: -11.89%
Dec 18, 2023
Maintains: Buy
Price Target: $66 → $69
Current: $49.74
Upside: +38.72%
Dec 18, 2023
Maintains: Hold
Price Target: $2 → $1
Current: $1.56
Upside: -35.69%
Sep 13, 2023
Reiterates: Buy
Price Target: $40
Current: $14.17
Upside: +182.39%
Aug 9, 2023
Initiates: Buy
Price Target: $40
Current: $1.00
Upside: +3,900.00%
Jul 18, 2023
Maintains: Buy
Price Target: $28 → $34
Current: $15.78
Upside: +115.46%
Dec 14, 2022
Initiates: Buy
Price Target: $33
Current: $1.63
Upside: +1,930.77%